Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

High levels of serum matrix metalloproteinases in dogs with natural visceral leishmaniosis: a preliminary report.

Melo GD, Marangoni NR, Marcondes M, Lima VM, Machado GF.

Vet J. 2011 May;188(2):243-5. doi: 10.1016/j.tvjl.2010.03.017. Epub 2010 Apr 24.

PMID:
20418130
2.

Canine cerebral leishmaniasis: potential role of matrix metalloproteinase-2 in the development of neurological disease.

Melo GD, Marcondes M, Machado GF.

Vet Immunol Immunopathol. 2012 Aug 15;148(3-4):260-6. doi: 10.1016/j.vetimm.2012.05.007. Epub 2012 May 11.

PMID:
22673195
3.

Levels of matrix metalloproteinase-2 and metalloproteinase-9 in the cerebrospinal fluid of dogs with visceral leishmaniasis.

Marangoni NR, Melo GD, Moraes OC, Souza MS, Perri SH, Machado GF.

Parasite Immunol. 2011 Jun;33(6):330-4. doi: 10.1111/j.1365-3024.2011.01285.x.

4.

Differential alterations in the activity of matrix metalloproteinases within the nervous tissue of dogs in distinct manifestations of visceral leishmaniasis.

Machado GF, Melo GD, Moraes OC, Souza MS, Marcondes M, Perri SH, Vasconcelos RO.

Vet Immunol Immunopathol. 2010 Aug 15;136(3-4):340-5. doi: 10.1016/j.vetimm.2010.03.024. Epub 2010 Apr 8.

PMID:
20430448
5.

Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.

Huang CY, Wu TC, Lin WT, Leu HB, Lin CP, Lin SJ, Chen JW.

Eur J Clin Invest. 2006 Feb;36(2):76-84.

PMID:
16436088
6.

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.

Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V.

Am Heart J. 2008 Jul;156(1):85-91. doi: 10.1016/j.ahj.2008.01.035.

PMID:
18585501
7.

Matrix metalloproteinases in blood from patients with LAM.

Odajima N, Betsuyaku T, Nasuhara Y, Inoue H, Seyama K, Nishimura M.

Respir Med. 2009 Jan;103(1):124-9. doi: 10.1016/j.rmed.2008.07.017. Epub 2008 Aug 29.

8.

[Interpretation of laboratory data during cryptic leishmaniasis in dog].

Gravino AE.

Parassitologia. 2004 Jun;46(1-2):227-9. Italian.

PMID:
15305723
9.

Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.

Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT.

Rheumatology (Oxford). 2006 Apr;45(4):414-20. Epub 2005 Nov 15.

PMID:
16287916
10.

Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.

Rautelin HI, Oksanen AM, Veijola LI, Sipponen PI, Tervahartiala TI, Sorsa TA, Lauhio A.

Ann Med. 2009;41(3):208-15. doi: 10.1080/07853890802482452.

PMID:
18979291
11.

Detection of serum MMPs in tumor-bearing hamsters.

Iki K, Takeo T, Kubozoe T, Aoki S, Hayashi J, Tsunoda T.

J Hepatobiliary Pancreat Surg. 2002;9(4):478-84.

PMID:
12483270
12.

Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.

Srinivas R, Sorsa T, Tjäderhane L, Niemi E, Raustia A, Pernu H, Teronen O, Salo T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):517-25.

PMID:
11346728
13.

Matrix metalloproteinases as novel disease markers in Takayasu arteritis.

Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, Nakamura T, Yamashita S, Matsuzawa Y.

Circulation. 2003 Sep 23;108(12):1469-73. Epub 2003 Sep 2.

14.

Matrix metalloproteinase-2 and -9 involvement in canine tumors.

Loukopoulos P, Mungall BA, Straw RC, Thornton JR, Robinson WF.

Vet Pathol. 2003 Jul;40(4):382-94.

PMID:
12824510
15.

Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.

Wang L, Pan Q, Xue Q, Cui J, Qi C.

Am J Vet Res. 2008 Oct;69(10):1341-5. doi: 10.2460/ajvr.69.10.1341.

PMID:
18828693
16.

Nodular lesions of the tongue in canine leishmaniosis.

Parpaglia ML, Vercelli A, Cocco R, Zobba R, Manunta ML.

J Vet Med A Physiol Pathol Clin Med. 2007 Oct;54(8):414-7.

PMID:
17877582
17.

High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.

Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kähäri VM, Pyrhönen S.

Clin Cancer Res. 2005 Jul 15;11(14):5158-66.

18.

Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil.

França-Silva JC, da Costa RT, Siqueira AM, Machado-Coelho GL, da Costa CA, Mayrink W, Vieira EP, Costa JS, Genaro O, Nascimento E.

Vet Parasitol. 2003 Feb 13;111(2-3):161-73.

PMID:
12531292
19.

Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.

Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.

Exp Eye Res. 2002 May;74(5):577-84.

PMID:
12076079
20.

Identification of ocular matrix metalloproteinases present within the aqueous humor and iridocorneal drainage angle tissue of normal and glaucomatous canine eyes.

Weinstein WL, Dietrich UM, Sapienza JS, Carmichael KP, Moore PA, Krunkosky TM.

Vet Ophthalmol. 2007 Nov-Dec;10 Suppl 1:108-16.

PMID:
17973842

Supplemental Content

Support Center